Skip to main content
. 2016 Nov 5;7(49):81541–81554. doi: 10.18632/oncotarget.13132

Table 4. Statistical analysis of TRPV1v3 in GBM.

Table 4A: Univariate Kaplan-Meier survival analysis and TRPV1v3 mRNA expression (log-rank test)
All patients (n = 44) N° events (n = 38) All patients (n = 44) N° events (n = 44)
Log-rank test P-value Log-rank test P-value
TRPV1v3 (low/high) 5.367 0.0205
TRPV1v3 (loss/expression) 11.90 0.0006
Table 4B: Multivariate Cox proportional hazard regression analysis of Kaplan-Meier survival analysis of TRPV1v3 mRNA expression in relation to survival rates
Relative risk (95% CI) All patients (n = 38/44)
TRPV1v3 (low/high) 2.25 (1,13-4.45) P = 0,0008
Relative risk (95% CI) All patients (n = 6/44)
TRPV1v3( loss/expression) 17.1 (3.40-85.10) P = 0.0011